To test the hypothesis that WFA disrupts vimentin IFs and impairs migration and invasion in vitro, we treated KPV+/+ cells and human lung adenocarcinoma (A549) cells with WFA (Fig. 3D and Supplementary Fig. S3A). This evidence concerns the gene VIM and lung adenocarcinoma.